Filana Therapeutics Inc (FLNA) Straddle

Trading a FLNA straddle lets you take a pure volatility position on Filana Therapeutics Inc without committing to a direction. Filana Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate FLNA straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on FLNA profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Filana Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the FLNA straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the FLNA straddle is the cleanest expression of that view. Our scanner prices every FLNA straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a FLNA straddle into a catalyst or short a FLNA straddle to harvest decay, the options straddle setups that matter are all in one place.